| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/20/1996 | WO1996018393A1 Novel compounds |
| 06/20/1996 | WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 06/20/1996 | WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 06/20/1996 | WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations |
| 06/20/1996 | WO1996018379A1 Cosmetic and dermatological preparations with flavonoids |
| 06/20/1996 | CA2165517A1 Diamine ethylene derivative used in a cosmetic or dermatologic composition containing a compound with an irritating secondary effect |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | EP0716850A1 Use of an ethylene diamine derivative in a cosmetic or dermatological composition and in compositions containing materials with irritant side effects |
| 06/19/1996 | EP0716849A1 Cosmetic or dermatological composition containing a mixture of ceramides and its use for moisturizing the skin |
| 06/19/1996 | EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid |
| 06/19/1996 | EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY |
| 06/19/1996 | EP0716592A1 Compositions against skin impurities and mild forms of acne containing lanolinic acid or lanolinic acid components as active substance |
| 06/19/1996 | EP0605504B1 Cosmetic and dermatological preparations |
| 06/19/1996 | EP0577718B1 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
| 06/19/1996 | CN1124925A Lotion |
| 06/18/1996 | US5527824 Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis |
| 06/18/1996 | US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
| 06/15/1996 | CA2164916A1 Vitamin d compounds and method of preparing these compounds |
| 06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 06/13/1996 | WO1996017819A1 Asiatic acid derivatives, its manufacturing method and dermatological agent containing it |
| 06/13/1996 | WO1996017624A1 Sunscreen-wound healing composition |
| 06/13/1996 | WO1996017615A1 Viscous liquid conditioning topical germicides |
| 06/13/1996 | WO1996003033A3 Use of a commiphora mukul extract as a pigmenting agent |
| 06/13/1996 | WO1994013260A3 Use of a simarouba extract to reduce patchy skin pigmentation |
| 06/12/1996 | EP0715852A1 Use of hyaluronic acid or its salt to treat skin disease |
| 06/12/1996 | EP0715613A1 New diphenylhexene |
| 06/12/1996 | CN1124250A 17-deoxycorticosteroid-21-|O¨-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 06/12/1996 | CN1124143A Powder preparation for healing damaged skin |
| 06/11/1996 | US5525625 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
| 06/11/1996 | US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine |
| 06/11/1996 | US5525602 Method of using 4-amino 6-substituted mycophenolic acid and derivatives |
| 06/11/1996 | US5525513 Isolated mammalian dna sequence which hybridizes to specified primers |
| 06/11/1996 | US5525502 DNA encoding chitin deacetylase |
| 06/06/1996 | WO1996016991A1 Cationic biopolymers |
| 06/06/1996 | WO1996016983A1 Cooperative combinations of ligands contained within a matrix |
| 06/06/1996 | WO1996016966A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 06/06/1996 | WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation |
| 06/06/1996 | WO1996016642A1 Matrix type patch preparation |
| 06/06/1996 | WO1996016632A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
| 06/06/1996 | CA2206303A1 Matrix type patch formulation |
| 06/06/1996 | CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation |
| 06/06/1996 | CA2206175A1 Cooperative combinations of ligands contained within a matrix |
| 06/06/1996 | CA2180745A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
| 06/05/1996 | EP0714418A1 Cosmetic melanins |
| 06/05/1996 | EP0714390A1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
| 06/05/1996 | EP0714304A1 Therapeutic system for treating psoriasis |
| 06/05/1996 | EP0714284A1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 06/05/1996 | DE4442987A1 Kationische Biopolymere Cationic biopolymers |
| 06/04/1996 | US5523457 Used for preventing or treating skin disorders like acne, psoriasis, damage for irradiation; antitumor agent |
| 06/04/1996 | US5523319 Compounds of the benzo-heterocycle family |
| 05/30/1996 | WO1996016049A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS |
| 05/30/1996 | WO1996016041A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
| 05/30/1996 | WO1996016036A1 18-nor-vitamin d compounds |
| 05/30/1996 | WO1996016035A1 18,19-dinor-vitamin d compounds |
| 05/30/1996 | WO1996015771A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 05/30/1996 | WO1996015669A1 Prophylactic treatment of allergic contact dermatitis |
| 05/30/1996 | CA2206876A1 18,19-dinor-vitamin d compounds |
| 05/30/1996 | CA2206873A1 18-nor-vitamin d compounds |
| 05/30/1996 | CA2205920A1 Prophylactic treatment of allergic contact dermatitis |
| 05/30/1996 | CA2205860A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 05/29/1996 | EP0713696A1 Topical application product containing a lipase and a precursor of hydroxyacid |
| 05/29/1996 | EP0713653A1 Fortified fruit juice |
| 05/29/1996 | EP0639179B1 23-oxa derivatives of d-series vitamins, method of preparing them, pharmaceutical preparations containing them, and the use of such preparations as drugs |
| 05/29/1996 | EP0618811A4 Proteolytic mixture containing escharase and method of isolating same. |
| 05/29/1996 | EP0506658B1 Compositions and method for treating painful, inflammatory or allergic disorders |
| 05/29/1996 | EP0415924B1 Regulation of cell proliferation and differentiation using peptides |
| 05/29/1996 | CN1123557A Process for obtaining high-purity egg oil and use thereof |
| 05/29/1996 | CN1123523A Methods of using hesperetin for sebum control and treatment of ACNE |
| 05/28/1996 | US5521207 Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 05/28/1996 | US5520926 Wound dressings |
| 05/28/1996 | US5520905 Cosmetic or dermatological preparation comprising delta-aminolevulinic acid content as an active ingredient |
| 05/24/1996 | CA2163466A1 Fortified fruit juices |
| 05/23/1996 | WO1996014868A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/23/1996 | WO1996014858A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 05/23/1996 | CA2204145A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/22/1996 | EP0712629A1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/22/1996 | EP0637299B1 20-methyl-substituted vitamin d derivates |
| 05/22/1996 | CN1122696A Inhalant for prevention and treatment of baldness |
| 05/21/1996 | US5519039 Pantothenic acid, nicotinic acid and biotin for skins |
| 05/21/1996 | US5519020 Polymer adducts which release nitric oxide |
| 05/21/1996 | US5519018 Substituted phenols and their use for the treatment of disorders caused by cell proliferation |
| 05/21/1996 | US5518733 Cosmetic compositions containing oligosaccharides |
| 05/21/1996 | CA1338337C Method and composition for the treatment of burns |
| 05/17/1996 | WO1996014339A1 Antibodies |
| 05/17/1996 | WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF |
| 05/17/1996 | WO1996014317A1 Novel piperidine derivatives with paf antagonist activity |
| 05/17/1996 | CA2203909A1 Identification of the p21waf1-pcna interaction site and therapeutic applications thereof |
| 05/15/1996 | EP0711778A1 Sunscreens, sunscreen compositions and use thereof |
| 05/15/1996 | EP0711552A1 Dermatologic compositions containing wool wax acids and fatty acid glycerides against superinfections |
| 05/15/1996 | EP0711539A1 Use of a salicylic acid derivative as stabilizer of oil-in-water emulsion, surfactants-free |
| 05/15/1996 | EP0711343A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0711168A1 Methods of treating apoptosis and associated conditions |
| 05/15/1996 | EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 05/15/1996 | EP0711141A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 05/15/1996 | DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen |
| 05/15/1996 | CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid |
| 05/14/1996 | US5516907 Antiinflammatory agents |
| 05/14/1996 | US5516778 Method for improving tissue antioxidant status |